75
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Commissural fiber degeneration in motor neuron diseases

&
Pages 321-323 | Received 12 Mar 2020, Accepted 30 Mar 2020, Published online: 14 Apr 2020

References

  • Smith MC. Nerve fibre degeneration in the brain in amiotrophyc lateral sclerosis. J Neurol Neurosurg Psychiatry. 1960;23:269–82.
  • Metwalli NS, Benatar M, Nair G, Usher S, Hu X, Carew JD. Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res. 2010;1348:156–64.
  • Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010;75:1645–52.
  • Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, et al. Patterns of cerebral and cerebellar white matter degeneration in ALS. J Neurol Neurosurg Psychiatry. 2015;86:468–70.
  • Bede P, Hardiman O. Lessons of ALS imaging: pitfalls and future directions – a critical review. NeuroImage Clinical. 2014;4:436–43.
  • Chapman MC, Jelsone-Swain L, Fling BW, Johnson TD, Gruis K, Welsh RC. Corpus callosum area in amyotrophic lateral sclerosis. Amyotroph Lateral Sc. 2012;13:589–91.
  • Schuster C, Elamin M, Hardiman O, Bede P. The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. Eur J Neurol. 2016;23:1361–71.
  • Floeter MK, Danielian LE, Braun LE, Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry. 2018;89:53–60.
  • Cardenas AM, Sarlls JE, Kwan JY, Bageac D, Gala ZS, Danielian LE, et al. Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study. NeuroImage Clin. 2017;15:200–8.
  • Meoded A, Kwan JY, Peters TL, Huey ED, Danielian LE, Wiggs E, et al. Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Disord Extra. 2013;3:233–50.
  • Chapman MC, Jelsone-Swain L, Johnson TD, Gruis KL, Welsh RC. Diffusion tensor MRI of the corpus callosum in amyotrophic lateral sclerosis. J Magn Reson Imaging. 2014;39:641–7
  • Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007;28:1430–8.
  • Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, et al. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Sc Frontotemporal Degener. 2017;18:611–623.
  • Bede P, Bokde AL, Byrne S, Elamin M, McLaughlin RL, Kenna K, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology 2013;81:361–9.
  • Yamauchi H, Fukuyama H, Ouchi Y, Nagahama Y, Kimura J, Asato R, et al. Corpus callosum atrophy in amyotrophic lateral sclerosis. J Neurol Sci. 1995;134:189–96.
  • Kassubek J, Unrath A, Huppertz HJ, Lule D, Ethofer T, Sperfeld AD, et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Sc. 2005;6:213–20.
  • Zhang J, Ji B, Hu J, Zhou C, Li L, Li Z, et al. Aberrant interhemispheric homotopic functional and structural connectivity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:369–70.
  • Wittstock M, Wolters A, Benecke R. Transcallosal inhibition in amyotrophic lateral sclerosis. Clin Neurophysiol. 2007;118:301–7.
  • Proudfoot M, Rohenkohl G, Quinn A, Colclough GL, Wuu J, Talbot K, Woolrich MW, Benatar M, et al. Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp. 2017;38:237–54.
  • Bede P. The histological correlates of imaging metrics: postmortem validation of in vivo findings. Amyotroph Lateral Sc Frontotemporal Degener. 2019;20:457–60.
  • Ng MC, Ho JT, Ho SL, Lee R, Li G, Cheng TS, Song YQ, Ho PW, et al. Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation. J Magn Reson Imaging. 2008;27:8–13.
  • Querin G, Bede P, El Mendili MM, Li M, Pelegrini-Issac M, Rinaldi D, et al. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann Neurol. 2019;86:158–67.
  • Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, Vidovszky AA, et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. NeuroImage Clin. 2017;14:286–97.
  • Wen J, Zhang H, Alexander DC, Durrleman S, Routier A, Rinaldi D, et al. Neurite density is reduced in the presymptomatic phase of C9orf72 disease. J Neurol Neurosurg Psychiatry. 2019;90:387–94.
  • Broad RJ, Gabel MC, Dowell NG, Schwartzman DJ, Seth AK, Zhang H, et al. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. J Neurol Neurosurg Psychiatry 2019;90:404–411.
  • Barritt AW, Gabel MC, Cercignani M, Leigh PN. Emerging magnetic resonance imaging techniques and analysis methods in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1065.
  • Bede P, Querin G, Pradat PF. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr Opin Neurol. 2018;31:431–8.
  • Querin G, El Mendili MM, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, et al. Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry. 2018;89:1220–1.
  • Bede P, Iyer PM, Finegan E, Omer T, Hardiman O. Virtual brain biopsies in amyotrophic lateral sclerosis: diagnostic classification based on in vivo pathological patterns. NeuroImage Clin. 2017;15:653–8.
  • Schuster C, Hardiman O, Bede P. Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using disease-specific pathognomonic features: a quantitative disease-state classification study. PLOS One. 2016;11:e0167331.
  • Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, Bede P. Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol. 2019;10:229.
  • Schuster C, Hardiman O, Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 2017;17:73.
  • Grollemund V, Pradat PF, Querin G, Delbot F, Le Chat G, Pradat-Peyre JF, et al. Machine learning in amyotrophic lateral sclerosis: achievements. Front Neurosci. 2019;13:135.
  • Menke RA, Korner S, Filippini N, Douaud G, Knight S, Talbot K, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain. 2014;137:2546–55.
  • Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotroph Lateral Sc Frontotemporal Degener. 2018;19:232–41.
  • Fortanier E, Grapperon AM, Le Troter A, Verschueren A, Ridley B, Guye M, et al. Structural connectivity alterations in amyotrophic lateral sclerosis: a graph theory based imaging study. Front Neurosci. 2019;13:1044.
  • Bede P. Deciphering neurodegeneration: a paradigm shift from focality to connectivity. Neurology. 2017;89:1758–9.
  • Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, et al. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018;12:1696–707.
  • Nasseroleslami B, Dukic S, Broderick M, Mohr K, Schuster C, Gavin B, et al. Characteristic increases in EEG connectivity correlate with changes of structural MRI in amyotrophic lateral sclerosis. Cereb Cortex. 2019;29:27–41.
  • Menke RAL, Proudfoot M, Talbot K, Turner MR. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;17:953–61.
  • Wittstock M, Meister S, Walter U, Benecke R, Wolters A. Mirror movements in amyotrophic lateral sclerosis. Amyotroph Lateral Sc. 2011;12:393–7.
  • Bede P, Iyer PM, Schuster C, Elamin M, McLaughlin RL, Kenna K, et al. The selective anatomical vulnerability of ALS: ‘disease-defining’ and ‘disease-defying’ brain regions. Amyotroph Lateral Sc Frontotemporal Degener. 2016;17:561–70.
  • Di Paola M, Di Iulio F, Cherubini A, Blundo C, Casini AR, Sancesario G, et al. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology. 2010;74:1136–42.
  • Qiu Y, Liu S, Hilal S, Loke YM, Ikram MK, Xu X, et al. Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI. Sci Rep. 2016;6:32573.
  • Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease. Neurology. 2017;88:1265–72.
  • Elahi FM, Marx G, Cobigo Y, Staffaroni AM, Kornak J, Tosun D, et al. Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer’s disease. NeuroImage Clin. 2017;16:595–603.
  • Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, et al. The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol. 2019;266:2718–33.
  • Unrath A, Muller HP, Riecker A, Ludolph AC, Sperfeld AD, Kassubek J. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp. 2010;31:1740.
  • Prendergast DM, Ardekani B, Ikuta T, John M, Peters B, DeRosse P, et al. Age and sex effects on corpus callosum morphology across the lifespan. Hum Brain Mapp. 2015;36:2691–702.
  • Bede P, Elamin M, Byrne S, Hardiman O. Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph Lateral Sc Frontotemporal Degener. 2014;15:235–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.